Edwin J.P. van Asseldonk

1.1k total citations · 1 hit paper
6 papers, 811 citations indexed

About

Edwin J.P. van Asseldonk is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Edwin J.P. van Asseldonk has authored 6 papers receiving a total of 811 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Edwin J.P. van Asseldonk's work include Adipokines, Inflammation, and Metabolic Diseases (4 papers), Immune Cell Function and Interaction (2 papers) and Bone Tumor Diagnosis and Treatments (1 paper). Edwin J.P. van Asseldonk is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (4 papers), Immune Cell Function and Interaction (2 papers) and Bone Tumor Diagnosis and Treatments (1 paper). Edwin J.P. van Asseldonk collaborates with scholars based in Netherlands and United States. Edwin J.P. van Asseldonk's co-authors include Jeremy S. Duffield, Lakshman Gunaratnam, Takaharu Ichimura, Benjamin D. Humphreys, Joseph V. Bonventre, Cees J. Tack, Mihai G. Netea, Rinke Stienstra, Leo A. B. Joosten and Tim B. Koenen and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Edwin J.P. van Asseldonk

6 papers receiving 799 citations

Hit Papers

Kidney injury molecule–1 is a phosphatidylserine receptor... 2008 2026 2014 2020 2008 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edwin J.P. van Asseldonk Netherlands 5 286 261 211 151 148 6 811
Weiguo Wan China 16 313 1.1× 267 1.0× 236 1.1× 113 0.7× 178 1.2× 35 887
Graciela Delgado Austria 14 322 1.1× 109 0.4× 169 0.8× 190 1.3× 90 0.6× 28 731
Alessandra Stasi Italy 21 386 1.3× 211 0.8× 322 1.5× 229 1.5× 115 0.8× 45 1.1k
Anurag Singh United Kingdom 9 428 1.5× 104 0.4× 203 1.0× 83 0.5× 79 0.5× 18 906
Manuel Alfredo Podestà Italy 19 538 1.9× 218 0.8× 235 1.1× 199 1.3× 85 0.6× 50 1.1k
Giovanni Conti Italy 18 396 1.4× 121 0.5× 211 1.0× 120 0.8× 49 0.3× 61 911
Rujuan Xie China 16 140 0.5× 209 0.8× 194 0.9× 96 0.6× 62 0.4× 33 742
Séverine Beaudreuil France 13 190 0.7× 169 0.6× 89 0.4× 140 0.9× 57 0.4× 43 630
Faysal Gök Türkiye 18 189 0.7× 87 0.3× 289 1.4× 169 1.1× 109 0.7× 70 934
Lichuan Yang China 18 363 1.3× 78 0.3× 194 0.9× 151 1.0× 84 0.6× 40 776

Countries citing papers authored by Edwin J.P. van Asseldonk

Since Specialization
Citations

This map shows the geographic impact of Edwin J.P. van Asseldonk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin J.P. van Asseldonk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin J.P. van Asseldonk more than expected).

Fields of papers citing papers by Edwin J.P. van Asseldonk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edwin J.P. van Asseldonk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin J.P. van Asseldonk. The network helps show where Edwin J.P. van Asseldonk may publish in the future.

Co-authorship network of co-authors of Edwin J.P. van Asseldonk

This figure shows the co-authorship network connecting the top 25 collaborators of Edwin J.P. van Asseldonk. A scholar is included among the top collaborators of Edwin J.P. van Asseldonk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin J.P. van Asseldonk. Edwin J.P. van Asseldonk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
2.
Ballak, Dov B., Edwin J.P. van Asseldonk, Janna A. van Diepen, et al.. (2015). TLR-3 is Present in Human Adipocytes, but Its Signalling is Not Required for Obesity-Induced Inflammation in Adipose Tissue In Vivo. PLoS ONE. 10(4). e0123152–e0123152. 26 indexed citations
3.
Asseldonk, Edwin J.P. van, et al.. (2011). Multiple osteolytic bone lesions.. PubMed. 69(9). 399, 403–399, 403. 2 indexed citations
4.
Asseldonk, Edwin J.P. van, Rinke Stienstra, Tim B. Koenen, et al.. (2011). Treatment with Anakinra Improves Disposition Index But Not Insulin Sensitivity in Nondiabetic Subjects with the Metabolic Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study. The Journal of Clinical Endocrinology & Metabolism. 96(7). 2119–2126. 118 indexed citations
5.
Asseldonk, Edwin J.P. van, Rinke Stienstra, Tim B. Koenen, et al.. (2010). The Effect of the Interleukin‐1 Cytokine Family Members IL‐1F6 and IL‐1F8 on Adipocyte Differentiation. Obesity. 18(11). 2234–2236. 32 indexed citations
6.
Ichimura, Takaharu, Edwin J.P. van Asseldonk, Benjamin D. Humphreys, et al.. (2008). Kidney injury molecule–1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. Journal of Clinical Investigation. 118(5). 1657–1668. 577 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026